Trump Modifies Federal Marijuana Restrictions

President Donald Trump has announced a shift in federal policy regarding marijuana.

On Thursday, Trump enacted an order that modifies marijuana's classification to Schedule III, aligning it with substances such as ketamine and anabolic steroids.

During an Oval Office event, Trump, accompanied by medical professionals, stated, "There are numerous individuals urging me for this change, people enduring severe pain."

Although this order stops short of legalizing marijuana outright, it facilitates a smoother pathway for scientific study of the plant.

According to Trump, advocates for this reclassification include those suffering from chronic pain, untreatable conditions, and seizure disorders. Trump highlighted the plant's potential medical benefits, particularly as an alternative to addictive opioids.

Another positive effect of this change could be the easing of financial pressures on marijuana businesses in states where it is already legal, including tax benefits.

Previously, marijuana was listed under Schedule I, a category reserved for drugs without accepted medicinal utility and with high abuse potential, per the Drug Enforcement Agency.

In contrast, Schedule III drugs exhibit a reduced potential for creating addiction, both physically and psychologically.

In anticipation of this announcement, marijuana stocks saw an increase as speculation about Trump's decision circulated.

While campaigning for a third presidential term in 2024, Trump indicated a more favorable stance towards marijuana than during his previous presidency.

He expressed his commitment to being a 'president of practical decisions,' which he reiterated upon signing the executive order.

Trump also communicated support for a Florida initiative that aimed to legalize marijuana for recreational use. Despite obtaining 56% of the vote, it fell short of the needed 60% for passage.

Furthermore, Trump emphasized a desire to establish laws simplifying operations for marijuana businesses by 2024.